Anne Chiplin

Anne Chiplin has a diverse work experience spanning over 17 years in the pharmaceutical industry. Anne most recently worked at Intercept Pharmaceuticals as the Director of Safety Evaluation and Risk Management Operations, where they ensured the evaluation and documentation of safety data as benefit-risk assessment reports. Anne also oversaw signal detection and management activities, risk communications, and provided scientific and managerial input for regulatory submissions and clinical research plans.

Prior to their role at Intercept Pharmaceuticals, Anne worked as an Associate Director of Pharmacovigilance and a Senior Manager of Pharmacovigilance at the same company. Anne also held the position of Manager of Safety Surveillance at SynteractHCR, where they managed safety surveillance activities.

Anne's previous experience includes working as a Senior Drug Safety Associate at Santarus, Inc. and as a Drug Safety Specialist III at Vical Inc. Anne began their career as a Clinical Coordinator at Parexel Intl.

Overall, Anne Chiplin has gained extensive experience in pharmacovigilance and drug safety throughout their career, demonstrating their expertise in ensuring the safety and risk management of pharmaceutical products.

Anne Chiplin holds a B.Pharm (Hons) degree in Pharmacy from the University of Nottingham, England. Anne also completed a pre-registration training at Westminster Hospital, London, England, which is a requirement for licensure in the field. Additionally, they pursued a Graduate Certificate program in Drug Development Process and Clinical Research Associate/Coordinator Training at the University of San Diego.